How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12916-024-03444-6
PubMed Identifier: 38840159
Publication URI: http://europepmc.org/abstract/MED/38840159
Type: Journal Article/Review
Volume: 22
Parent Publication: BMC medicine
Issue: 1
ISSN: 1741-7015